Search research articles
Contact Us
Filters
Showing results (501-510 of 688) with videos related to
Page
of 69
Sort By:
International Journal of Cardiology
|
July 19, 2006
Statin use and survival in patients with chronic heart failure--results from two observational studies with 5200 patients
Stefan D Anker, Andrew L Clark, Ralf Winkler, et al.
Circulation
|
July 11, 2007
Prediction of mode of death in heart failure: the Seattle Heart Failure Model
Dariush Mozaffarian, Stefan D Anker, Inder Anand, et al.
Circulation. Heart Failure
|
November 20, 2013
Cardiac structure and function in heart failure with preserved ejection fraction: baseline findings from the echocardiographic study of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist trial
Amil M Shah, Sanjiv J Shah, Inder S Anand, et al.
ESC Heart Failure
|
July 9, 2025
Clinical endpoints in pragmatic heart failure trials: From data collection to clinical endpoint classification
Veraprapas Kittipibul, Harriette G C Van Spall, William Schuyler Jones, et al.
ESC Heart Failure
|
September 3, 2024
Finerenone and left ventricular hypertrophy in chronic kidney disease and type 2 diabetes
Gerasimos Filippatos, Stefan D Anker, George L Bakris, et al.
European Heart Journal
|
March 17, 2012
Diabetes clinical trials: helped or hindered by the current shift in regulatory requirements?
Faiez Zannad, Wendy Gattis Stough, Stuart J Pocock, et al.
European Journal of Heart Failure
|
January 17, 2020
Predictors of sudden cardiac death in high-risk patients following a myocardial infarction
Kieran F Docherty, João Pedro Ferreira, Abhinav Sharma, et al.
Diabetes Care
|
August 16, 2022
Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium-Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis
Peter Rossing, Stefan D Anker, Gerasimos Filippatos, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
August 30, 2008
Cardiovascular protection for all individuals at high risk: evidence-based best practice
George Bakris, Michael Böhm, Gilles Dagenais, et al.
American Heart Journal
|
December 6, 2011
Rationale and design of the treatment of preserved cardiac function heart failure with an aldosterone antagonist trial: a randomized, controlled study of spironolactone in patients with symptomatic heart failure and preserved ejection fraction
Akshay S Desai, Eldrin F Lewis, Rebecca Li, et al.
Page
of 69
Search research articles
Search
Showing results (501-510 of 688) with videos related to
Sort By:
Page
of 69
International Journal of Cardiology
|
July 19, 2006
Statin use and survival in patients with chronic heart failure--results from two observational studies with 5200 patients
Stefan D Anker, Andrew L Clark, Ralf Winkler, et al.
Circulation
|
July 11, 2007
Prediction of mode of death in heart failure: the Seattle Heart Failure Model
Dariush Mozaffarian, Stefan D Anker, Inder Anand, et al.
Circulation. Heart Failure
|
November 20, 2013
Cardiac structure and function in heart failure with preserved ejection fraction: baseline findings from the echocardiographic study of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist trial
Amil M Shah, Sanjiv J Shah, Inder S Anand, et al.
ESC Heart Failure
|
July 9, 2025
Clinical endpoints in pragmatic heart failure trials: From data collection to clinical endpoint classification
Veraprapas Kittipibul, Harriette G C Van Spall, William Schuyler Jones, et al.
ESC Heart Failure
|
September 3, 2024
Finerenone and left ventricular hypertrophy in chronic kidney disease and type 2 diabetes
Gerasimos Filippatos, Stefan D Anker, George L Bakris, et al.
European Heart Journal
|
March 17, 2012
Diabetes clinical trials: helped or hindered by the current shift in regulatory requirements?
Faiez Zannad, Wendy Gattis Stough, Stuart J Pocock, et al.
European Journal of Heart Failure
|
January 17, 2020
Predictors of sudden cardiac death in high-risk patients following a myocardial infarction
Kieran F Docherty, João Pedro Ferreira, Abhinav Sharma, et al.
Diabetes Care
|
August 16, 2022
Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium-Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis
Peter Rossing, Stefan D Anker, Gerasimos Filippatos, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
August 30, 2008
Cardiovascular protection for all individuals at high risk: evidence-based best practice
George Bakris, Michael Böhm, Gilles Dagenais, et al.
American Heart Journal
|
December 6, 2011
Rationale and design of the treatment of preserved cardiac function heart failure with an aldosterone antagonist trial: a randomized, controlled study of spironolactone in patients with symptomatic heart failure and preserved ejection fraction
Akshay S Desai, Eldrin F Lewis, Rebecca Li, et al.
Page
of 69